Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT04328727
Status:
COMPLETED
Last Update Posted:
2025-07-17
First Post:
2020-03-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-06
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-09
First Submit QC Date:
None
Study First Post Date:
2020-03-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-04
Results First Submit QC Date:
None
Results First Post Date:
2025-07-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-30
Last Update Post Date:
2025-07-17
Last Update Post Date Type:
ACTUAL